• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤源性CXCL8信号增强了基质源性CCL2促进的PTEN缺陷型前列腺癌细胞增殖以及CXCL12介导的侵袭。

Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.

作者信息

Maxwell Pamela J, Neisen Jessica, Messenger Johanna, Waugh David J J

机构信息

Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland.

出版信息

Oncotarget. 2014 Jul 15;5(13):4895-908. doi: 10.18632/oncotarget.2052.

DOI:10.18632/oncotarget.2052
PMID:24970800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4148108/
Abstract

Impaired PTEN function is a genetic hallmark of aggressive prostate cancers (CaP) and is associated with increased CXCL8 expression and signaling. The current aim was to further characterize biological responses and mechanisms underpinning CXCL8-promoted progression of PTEN-depleted prostate cancer, focusing on characterizing the potential interplay between CXCL8 and other disease-promoting chemokines resident within the prostate tumor microenvironment. Autocrine CXCL8-stimulation (i) increased expression of CXCR1 and CXCR2 in PTEN-deficient CaP cells suggesting a self-potentiating signaling axis and (ii) induced expression of CXCR4 and CCR2 in PTEN-wild-type and PTEN-depleted CaP cells. In contrast, paracrine CXCL8 signaling induced expression and secretion of the chemokines CCL2 and CXCL12 from prostate stromal WPMY-1 fibroblasts and monocytic macrophage-like THP-1 cells. In vitro studies demonstrated functional co-operation of tumor-derived CXCL8 with stromal-derived chemokines. CXCL12-induced migration of PC3 cells and CCL2-induced proliferation of prostate cancer cells were dependent upon intrinsic CXCL8 signaling within the prostate cancer cells. For example, in co-culture experiments, CXCL12/CXCR4 signaling but not CCL2/CCR2 signaling supported fibroblast-mediated migration of PC3 cells while CXCL12/CXCR4 and CCL2/CCR2 signaling underpinned monocyte-enhanced migration of PC3 cells. Combined inhibition of both CXCL8 and CXCL12 signaling was more effective in inhibiting fibroblast-promoted cell motility while repression of CXCL8 attenuated CCL2-promoted proliferation of prostate cancer cells. We conclude that tumor-derived CXCL8 signaling from PTEN-deficient tumor cells increases the sensitivity and responsiveness of CaP cells to stromal chemokines by concurrently upregulating receptor expression in cancer cells and inducing stromal chemokine synthesis. Combined chemokine targeting may be required to inhibit their multi-faceted actions in promoting the invasion and proliferation of aggressive CaP.

摘要

PTEN功能受损是侵袭性前列腺癌(CaP)的遗传特征,且与CXCL8表达及信号传导增加相关。当前的目标是进一步明确CXCL8促进PTEN缺失型前列腺癌进展的生物学反应及机制,重点是明确CXCL8与前列腺肿瘤微环境中其他促疾病趋化因子之间潜在的相互作用。自分泌CXCL8刺激(i)增加了PTEN缺陷型CaP细胞中CXCR1和CXCR2的表达,提示存在自我增强信号轴,以及(ii)在PTEN野生型和PTEN缺失型CaP细胞中诱导CXCR4和CCR2的表达。相反,旁分泌CXCL8信号诱导前列腺基质WPMY-1成纤维细胞和单核巨噬细胞样THP-1细胞表达并分泌趋化因子CCL2和CXCL12。体外研究证明肿瘤来源的CXCL8与基质来源的趋化因子存在功能协同作用。CXCL12诱导PC3细胞迁移以及CCL2诱导前列腺癌细胞增殖依赖于前列腺癌细胞内的固有CXCL8信号。例如,在共培养实验中,CXCL12/CXCR4信号而非CCL2/CCR2信号支持成纤维细胞介导的PC3细胞迁移,而CXCL12/CXCR4和CCL2/CCR2信号则是单核细胞增强PC3细胞迁移的基础。联合抑制CXCL8和CXCL12信号在抑制成纤维细胞促进的细胞运动方面更有效,而抑制CXCL8则减弱了CCL2促进的前列腺癌细胞增殖。我们得出结论,PTEN缺陷型肿瘤细胞来源的CXCL8信号通过同时上调癌细胞中的受体表达并诱导基质趋化因子合成,增加了CaP细胞对基质趋化因子的敏感性和反应性。可能需要联合靶向趋化因子来抑制它们在促进侵袭性CaP侵袭和增殖方面的多方面作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/e8810381de04/oncotarget-05-4895-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/d5cf3092c15b/oncotarget-05-4895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/7c233745c0f2/oncotarget-05-4895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/1307a55bb156/oncotarget-05-4895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/a3fc1d835892/oncotarget-05-4895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/6c2f238409bc/oncotarget-05-4895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/be1102bf4159/oncotarget-05-4895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/e8810381de04/oncotarget-05-4895-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/d5cf3092c15b/oncotarget-05-4895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/7c233745c0f2/oncotarget-05-4895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/1307a55bb156/oncotarget-05-4895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/a3fc1d835892/oncotarget-05-4895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/6c2f238409bc/oncotarget-05-4895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/be1102bf4159/oncotarget-05-4895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/4148108/e8810381de04/oncotarget-05-4895-g007.jpg

相似文献

1
Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.肿瘤源性CXCL8信号增强了基质源性CCL2促进的PTEN缺陷型前列腺癌细胞增殖以及CXCL12介导的侵袭。
Oncotarget. 2014 Jul 15;5(13):4895-908. doi: 10.18632/oncotarget.2052.
2
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.PTEN 缺陷型前列腺癌中炎症 CXCL8 信号的增强维持细胞存活。
Eur Urol. 2013 Aug;64(2):177-88. doi: 10.1016/j.eururo.2012.08.032. Epub 2012 Aug 28.
3
Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.迈向原位组织修复:人间充质干细胞表达趋化因子受体CXCR1、CXCR2和CCR2,并在受到CXCL8刺激时迁移,但不受CCL2刺激。
J Cell Biochem. 2007 May 1;101(1):135-46. doi: 10.1002/jcb.21172.
4
CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.CXCL8/白细胞介素-8和CXCL12/基质细胞衍生因子-1α协同促进胰腺癌的侵袭和血管生成。
Int J Cancer. 2009 Feb 15;124(4):853-61. doi: 10.1002/ijc.24040.
5
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.组成型和治疗诱导的 CXCL8 信号选择性调节转移性前列腺癌中抗代谢疗法的疗效。
PLoS One. 2012;7(5):e36545. doi: 10.1371/journal.pone.0036545. Epub 2012 May 9.
6
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.共同产生的CC趋化因子和CXC趋化因子通过受体介导的事件在单核细胞趋化中发挥协同作用。
Mol Pharmacol. 2008 Aug;74(2):485-95. doi: 10.1124/mol.108.045146. Epub 2008 May 9.
7
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.PTEN 缺失介导的 Akt 激活通过 CXCL12/CXCR4 信号促进前列腺肿瘤生长和转移。
Mol Cancer. 2013 Jul 31;12(1):85. doi: 10.1186/1476-4598-12-85.
8
Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.成纤维细胞衍生的 CXCL12 通过 PI3k/Akt 信号通路调节 PTEN 表达,并与结肠癌细胞的增殖和侵袭相关。
Cell Commun Signal. 2019 Sep 10;17(1):119. doi: 10.1186/s12964-019-0432-5.
9
Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.雄激素受体与趋化因子受体4和7形成一个信号轴,以调节依赖于CXCL12的细胞运动。
BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.
10
Multi-faceted roles for CXC-chemokines in prostate cancer progression.CXC趋化因子在前列腺癌进展中的多方面作用
Front Biosci. 2008 May 1;13:4595-604. doi: 10.2741/3025.

引用本文的文献

1
Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment.探索两种肿瘤治疗策略:核糖体失活蛋白和间充质干细胞/MSC衍生的细胞外囊泡在癌症治疗中的有效性。
Front Oncol. 2025 May 13;15:1533065. doi: 10.3389/fonc.2025.1533065. eCollection 2025.
2
Molecular Interplay Between PTEN, ARID1A, PD-L1, and MMR in Asian Ovarian Clear Cell Carcinoma: Implications for Immunotherapy Response and Patient Stratification.亚洲卵巢透明细胞癌中PTEN、ARID1A、PD-L1和错配修复之间的分子相互作用:对免疫治疗反应和患者分层的意义
Int J Mol Sci. 2025 May 20;26(10):4915. doi: 10.3390/ijms26104915.
3

本文引用的文献

1
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.针对富含纤维母细胞激活蛋白(FAP)的癌相关成纤维细胞中的 CXCL12 进行靶向治疗,与抗 PD-L1 免疫疗法联合应用于胰腺癌。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7. doi: 10.1073/pnas.1320318110. Epub 2013 Nov 25.
2
Tracking the clonal origin of lethal prostate cancer.追踪致命性前列腺癌的克隆起源。
J Clin Invest. 2013 Nov;123(11):4918-22. doi: 10.1172/JCI70354. Epub 2013 Oct 25.
3
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.
In Silico Analysis of miRNA-Mediated Genes in the Regulation of Dog Testes Development from Immature to Adult Form.
miRNA介导的基因在犬睾丸从幼龄到成年形态发育调控中的计算机模拟分析
Animals (Basel). 2023 Apr 30;13(9):1520. doi: 10.3390/ani13091520.
4
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts.整合鉴定前列腺上皮细胞或癌细胞与成纤维细胞之间细胞间通讯相关分泌因子。
Mol Oncol. 2023 Mar;17(3):469-486. doi: 10.1002/1878-0261.13376. Epub 2023 Jan 27.
5
Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.前列腺癌中骨转移前生态位的形成与中医调控
Front Pharmacol. 2022 Aug 17;13:897942. doi: 10.3389/fphar.2022.897942. eCollection 2022.
6
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.难治性前列腺癌中的免疫治疗与免疫抑制信号传导
Biomedicines. 2022 Jul 22;10(8):1778. doi: 10.3390/biomedicines10081778.
7
CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer.CXCL8 的表达与结直肠癌的晚期、右侧和独特的组织学特征相关。
J Pathol Clin Res. 2022 Nov;8(6):509-520. doi: 10.1002/cjp2.290. Epub 2022 Jul 25.
8
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers.抑制适应性 VEGF-A 和 IL8 信号可恢复 AR 拮抗剂治疗的前列腺癌的持久肿瘤控制。
Mol Cancer Res. 2022 Jun 3;20(6):841-853. doi: 10.1158/1541-7786.MCR-21-0780.
9
The tumor microenvironment and immune responses in prostate cancer patients.前列腺癌患者的肿瘤微环境和免疫反应。
Endocr Relat Cancer. 2021 Jul 15;28(8):T95-T107. doi: 10.1530/ERC-21-0149.
10
Inflammation-Induced Tumorigenesis and Metastasis.炎症诱导的肿瘤发生和转移。
Int J Mol Sci. 2021 May 21;22(11):5421. doi: 10.3390/ijms22115421.
PTEN 缺失与 ERG 阳性前列腺癌的侵袭性行为有关。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2333-44. doi: 10.1158/1055-9965.EPI-13-0333-T. Epub 2013 Oct 1.
4
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.ETS 因子重编程雄激素受体染色质,并对 PTEN 缺失作出反应,引发前列腺肿瘤发生。
Nat Med. 2013 Aug;19(8):1023-9. doi: 10.1038/nm.3216. Epub 2013 Jun 30.
5
Advancing precision medicine for prostate cancer through genomics.通过基因组学推进前列腺癌精准医学。
J Clin Oncol. 2013 May 20;31(15):1866-73. doi: 10.1200/JCO.2012.45.3662. Epub 2013 Apr 15.
6
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.PTEN 缺陷型前列腺癌中炎症 CXCL8 信号的增强维持细胞存活。
Eur Urol. 2013 Aug;64(2):177-88. doi: 10.1016/j.eururo.2012.08.032. Epub 2012 Aug 28.
7
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer.PTEN 表达缺失与局限性前列腺癌前列腺切除术后复发风险增加相关。
Mod Pathol. 2012 Nov;25(11):1543-9. doi: 10.1038/modpathol.2012.104. Epub 2012 Jun 8.
8
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.组成型和治疗诱导的 CXCL8 信号选择性调节转移性前列腺癌中抗代谢疗法的疗效。
PLoS One. 2012;7(5):e36545. doi: 10.1371/journal.pone.0036545. Epub 2012 May 9.
9
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.c-MYC 和 PTEN 的拷贝数改变是前列腺癌放疗后复发的预后因素。
Cancer. 2012 Aug 15;118(16):4053-62. doi: 10.1002/cncr.26729. Epub 2012 Jan 26.
10
Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.PTEN、ERG、SPINK1 和 AR 在去势抵抗性前列腺癌中的相互作用和关系。
Histopathology. 2012 Mar;60(4):645-52. doi: 10.1111/j.1365-2559.2011.04116.x. Epub 2012 Jan 19.